Fluorescence in situ hybridization as a tool to characterize genetic alterations in pancreatic adenocarcinoma.
Genevay
Muriel
M
Dumonceau
Jean-Marc
JM
Pepey
Béatrice
B
Pache
Jean-Claude
JC
Rubbia-Brandt
Laura
L
McKee
Thomas Alexander
TA
D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics*; D002869:Chromosome Aberrations; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D051901:Smad4 Protein / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D019941:Cyclin-Dependent Kinase Inhibitor p16; C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc; C497796:SMAD4 protein, human; D051901:Smad4 Protein; D016159:Tumor Suppressor Protein p53